IL85855A - 7-substituted -2,3,4,5-tetra- hydro-1h-3- benzazepines, their preparation and pharmaceutical compositions containing them - Google Patents

7-substituted -2,3,4,5-tetra- hydro-1h-3- benzazepines, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL85855A
IL85855A IL85855A IL8585588A IL85855A IL 85855 A IL85855 A IL 85855A IL 85855 A IL85855 A IL 85855A IL 8585588 A IL8585588 A IL 8585588A IL 85855 A IL85855 A IL 85855A
Authority
IL
Israel
Prior art keywords
substituted
alkyl
benzazepines
preparation
pharmaceutical compositions
Prior art date
Application number
IL85855A
Other languages
English (en)
Other versions
IL85855A0 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL85855A0 publication Critical patent/IL85855A0/xx
Priority to IL102779A priority Critical patent/IL102779A0/xx
Publication of IL85855A publication Critical patent/IL85855A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL85855A 1987-03-27 1988-03-24 7-substituted -2,3,4,5-tetra- hydro-1h-3- benzazepines, their preparation and pharmaceutical compositions containing them IL85855A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL102779A IL102779A0 (en) 1987-03-27 1992-08-10 Benzazepine compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3213587A 1987-03-27 1987-03-27

Publications (2)

Publication Number Publication Date
IL85855A0 IL85855A0 (en) 1988-09-30
IL85855A true IL85855A (en) 1993-02-21

Family

ID=21863286

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85855A IL85855A (en) 1987-03-27 1988-03-24 7-substituted -2,3,4,5-tetra- hydro-1h-3- benzazepines, their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
EP (2) EP0357641A1 (de)
JP (1) JPH0662574B2 (de)
KR (1) KR930011489B1 (de)
AT (1) ATE112766T1 (de)
AU (1) AU619744B2 (de)
CA (1) CA1321195C (de)
DE (1) DE3851769T2 (de)
DK (1) DK165688C (de)
FI (1) FI894566A7 (de)
HU (1) HU205744B (de)
IL (1) IL85855A (de)
MY (1) MY103357A (de)
NO (1) NO174507B (de)
NZ (1) NZ224038A (de)
PH (1) PH27337A (de)
PT (1) PT87068B (de)
WO (1) WO1988007526A1 (de)
ZA (1) ZA882080B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK107688D0 (da) * 1988-03-01 1988-03-01 Novo Industri As Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
ZA914536B (en) * 1990-06-15 1992-03-25 Schering Corp 8-lower alkyl-5-cycloalkyl or 5-cycloakenyl substituted benzazepines and pharmaceutical compositions containing them
EP0551312A1 (de) * 1990-09-25 1993-07-21 Schering Corporation Peri-kondensierte benzazepine
US5241065A (en) * 1992-02-25 1993-08-31 Schering Corporation 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
ES2250432T3 (es) * 2000-07-05 2006-04-16 Ortho-Mcneil Pharmaceutical, Inc. Espirobenzoazepinas no peptidicas sustituidas, antagonistas de la vasopresina.
US6953787B2 (en) * 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
PT1572215E (pt) * 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
EP1646623A2 (de) 2003-05-22 2006-04-19 Schering Corporation 5-h-benzo[d]naphth[2,1-b]azepinderivate als selektive d1/d5-rezeptorantagonisten zur behandlung von obesitas und zns-erkrankungen
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
CN1805938B (zh) * 2003-06-17 2010-06-16 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
AU2012200805B2 (en) * 2003-06-17 2015-01-22 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
WO2005042491A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
EP2149562A1 (de) 2004-12-21 2010-02-03 Arena Pharmaceuticals, Inc. Verfahren zur Herstellung des (R)-8-Chlor-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinhydrochlorid-Hemihydrat
NZ589951A (en) 2004-12-23 2012-11-30 Arena Pharm Inc 5HT2C receptor modulator compositions and methods of use
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
EP2099743B1 (de) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Verfahren zur herstellung von (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin und zwischenprodukten davon
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
JP2013539470A (ja) 2010-09-01 2013-10-24 アリーナ ファーマシューティカルズ, インコーポレイテッド ロルカセリンと光学活性な酸との塩
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
EA201390335A1 (ru) 2010-09-01 2013-09-30 Арена Фармасьютикалз, Инк. Введение лоркасерина индивидуумам с почечной недостаточностью
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
RU2674670C1 (ru) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Способ коррекции массы тела
HU230826B1 (hu) 2014-11-19 2018-07-30 Richter Gedeon Nyrt. Eljárás benzazepin származékok előállítására

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
DE1934150A1 (de) * 1968-07-10 1970-01-15 Pennwalt Corp Neue 1-Alkanoyloxy-1,2,4,5-tetrahydro-3H,3-benzazepine
US4988690A (en) * 1982-06-14 1991-01-29 Hoechst-Roussel Pharmaceuticals Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
US4707483A (en) * 1985-12-20 1987-11-17 Smithkline Beckman Corporation 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof

Also Published As

Publication number Publication date
PT87068A (pt) 1988-04-01
DK652688A (da) 1988-11-23
HUT53882A (en) 1990-12-28
NO885096D0 (no) 1988-11-15
ZA882080B (en) 1989-04-26
DK165688C (da) 1993-05-24
DE3851769T2 (de) 1995-03-09
CA1321195C (en) 1993-08-10
NZ224038A (en) 1990-10-26
JPH02502723A (ja) 1990-08-30
IL85855A0 (en) 1988-09-30
MY103357A (en) 1993-06-30
NO174507C (de) 1994-05-18
KR890700577A (ko) 1989-04-25
AU619744B2 (en) 1992-02-06
NO885096L (no) 1988-11-15
WO1988007526A1 (en) 1988-10-06
HU205744B (en) 1992-06-29
AU1596488A (en) 1988-11-02
DK165688B (da) 1993-01-04
FI894566A0 (fi) 1989-09-27
EP0285919B1 (de) 1994-10-12
DE3851769D1 (de) 1994-11-17
ATE112766T1 (de) 1994-10-15
JPH0662574B2 (ja) 1994-08-17
PH27337A (en) 1993-06-08
PT87068B (pt) 1992-07-31
DK652688D0 (da) 1988-11-23
EP0357641A1 (de) 1990-03-14
NO174507B (no) 1994-02-07
FI894566A7 (fi) 1989-09-27
KR930011489B1 (ko) 1993-12-08
EP0285919A1 (de) 1988-10-12

Similar Documents

Publication Publication Date Title
NO174507C (de)
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
HUT57722A (en) Process for producing azaspiran derivatives and pharmaceutical compositions comprising such compounds
HUT68762A (en) Fungicidal composition containing carboxyanilide and process for their preparation
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
HUT62296A (en) Herbicidal composition comprising hydantoin derivative as active ingredient and process for producing the active ingredient
AU1832988A (en) Thiazole derivatives
DE3873578D1 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
EP1147772A4 (de) Medizinische zusammensetzungen zur behandlung der vorhof-fibrillation
DE3171116D1 (en) Arylamine derivatives, process for their preparation and their use as microbicides
GB8816773D0 (en) Insecticidal compounds characterised by enhanced knockdown effect
GB8925032D0 (en) Chemical compounds
HUT54277A (en) Fungicidal compositions comprising 3-(methoxyimino)-propionic acid esters as active ingredient and process for producing the active ingredients
DE3671012D1 (de) 5-alkylsulfonylsalicylanilide und mikrobizide zusammensetzungen fuer die regulierung des wachstums von mikroorganismen.
DE69309461D1 (de) Zusammensetzung zur Beschleunigung der Wundheilung
ZA918518B (en) 8-azabicyclo(3.2.1)octylalkylthiazolidinones,a process for their preparation and their use as medicaments
PL264320A1 (en) A fungicide and a method of active matter production
GR3026397T3 (en) Para-hydroxyaniline derivatives, process for their preparation and their use as fungicides or pesticides.
HUT59083A (en) Improved process for producing 4-methyl-sulfonyl-benzoic acid derivatives
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
ES8400751A1 (es) "procedimiento para preparar nuevos derivados organofosfonados".
DE69129605D1 (de) Verfahren zur Herstellung von N-Alkylpyrazolen
MY103596A (en) Insecticidal compounds - characterised by enhanced knockdown effect.
AU5977980A (en) Aminodeoxyclavulanic acids

Legal Events

Date Code Title Description
RH Patent void